Market revenue in 2021 | USD 293.2 million |
Market revenue in 2028 | USD 499.2 million |
Growth rate | 7.9% (CAGR from 2021 to 2028) |
Largest segment | Synthetic |
Fastest growing segment | Synthetic |
Historical data covered | 2016 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Natural, Synthetic, Hybrid |
Key market players worldwide | Galderma Group AG Registered Shares, Johnson & Johnson, Bausch & Lomb Corp, Medtronic PLC, Ocular Therapeutix Inc, Fresenius SE & Co KGaA, Blairex Laboratories, Ferring, Endo Pharmaceuticals, TOLMAR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hydrogel-based drug delivery system market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 56.17% in 2021. Horizon Databook has segmented the Latin America hydrogel-based drug delivery system market based on natural, synthetic, hybrid covering the revenue growth of each sub-segment from 2016 to 2028.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America hydrogel-based drug delivery system market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America hydrogel-based drug delivery system market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account